Walleye Trading LLC Cara Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $141,192 - $203,043	15,900 New	15,900 $170,000
Q2 2022 Aug 08, 2022	SELL	$7.45 - $13.84 $107,280 - $199,296	-14,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.94 - $12.65 $100,394 - $127,765	10,100 Added 234.88%	14,400 $175,000
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $25,179 - $38,094	-2,100 Reduced 32.81%	4,300 $52,000
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $73,920 - $102,783	6,400 New	6,400 $99,000
Q2 2020 Aug 14, 2020	SELL	$12.39 - $17.33 $37,170 - $51,989	-3,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.12 - $17.78 $27,359 - $53,340	3,000 New	3,000 $40,000
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $104,312 - $127,263	-5,900 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$14.41 - $19.64 $96,547 - $131,588	-6,700 Reduced 53.17%	5,900 $116,000
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $229,080 - $431,848	-18,400 Reduced 59.35%	12,600 $164,000
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $544,670 - $742,450	31,000 New	31,000 $742,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.1M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.